Introduction/Overview Terbutaline represents a cornerstone agent within the therapeutic arsenal for obstructive pulmonary diseases. As a selective beta2-adrenergic receptor agonist, its primary clinical utility lies in the relief of bronchospasm.…

Introduction/Overview Salmeterol xinafoate represents a cornerstone in the maintenance therapy of obstructive airway diseases, specifically asthma and chronic obstructive pulmonary disease (COPD). As a long-acting beta2-adrenoceptor agonist (LABA), it provides…

Introduction/Overview Misoprostol is a synthetic prostaglandin E1 (PGE1) analog with a diverse and critical profile of therapeutic applications. Initially developed for the prevention of gastric mucosal injury associated with nonsteroidal…

1. Introduction/Overview Sumatriptan represents a cornerstone in the acute pharmacological management of migraine and cluster headache disorders. As the first agent developed in the triptan class, its introduction in the…

Introduction/Overview Pentazocine is a synthetically derived opioid analgesic with a distinctive pharmacological profile, classified as an opioid agonist-antagonist. First synthesized in the 1960s, it was developed in an effort to…

Introduction/Overview Buprenorphine represents a cornerstone agent in the management of opioid use disorder and chronic pain, distinguished by its unique pharmacodynamic profile as a partial agonist at the mu-opioid receptor.…

Introduction/Overview Mefenamic acid is a non-steroidal anti-inflammatory drug (NSAID) belonging to the fenamate class, which has been utilized in clinical practice for several decades. It is distinguished from other NSAIDs…

Introduction/Overview Ketorolac tromethamine represents a significant agent within the nonsteroidal anti-inflammatory drug (NSAID) class, distinguished primarily by its potent analgesic properties. Developed in the 1970s and approved for clinical use…